Amgen Nails Earnings, Guidance a Different Story

Health and Healthcare

Published: January 28, 2014 4:13 pm

Last Updated: January 29, 2014 7:53 am

Amgen Inc. (NASDAQ: AMGN) is the second largest biotech player, and now we have seen its fourth-quarter earnings report. Earnings came in up 30% at $1.82 per share, and revenue was up 13% to $5.01 billion. Thomson Reuters had estimates of $1.68 in earnings per share and $4.82 billion in revenue. Product sales were up 11% in the quarter.

Guidance for all of 2014 was put at $7.90 to $8.20 in earnings per share and $19.2 to $19.6 billion in revenue. Thomson Reuters had estimates of $8.18 in earnings per share and $19.58 billion in revenue.

Amgen now has 10 drug development programs with registration-enabling data expected by 2016. It also claims to have six biosimilars in development and has expanded presence in more than 75 countries.

Neulasta and Neupogen sales combined were up 8% for the quarter, and some select product sales growth was as follows: Enbrel up 3% (driven by price), Aranesp dropped 4% on lower unit demand, Sensipar/Mimpara sales increased 20% based on unit demand and price.

Amgen shares closed up 1.8% at $120.70, against a 52-week range of $39.24 to $84.40. The after-hours reaction had shares down only a few pennies initially.

Are You Still Paying With a Debit Card?

The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.

Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!

Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!

Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.